Development and characterization of evening primrose (Oenothera biennis) oil nanoemulsions

被引:35
|
作者
Rodrigues, Railane F. [1 ]
Costa, Isabele C. [1 ]
Almeida, Fernanda B. [1 ]
Cruz, Rodrigo A. S. [1 ]
Ferreira, Adriana M. [2 ]
Vilhena, Jessica C. E.
Florentino, Alexandro C. [3 ]
Carvalho, Jose C. T. [2 ]
Fernandes, Caio P. [1 ]
机构
[1] Univ Fed Amapa, Curso Farm, Lab Nanobiotecnol Fitofarmaceut, Macapa, AP, Brazil
[2] Univ Fed Amapa, Curso Farm, Lab Pesquisa Farmacos, Macapa, AP, Brazil
[3] Univ Fed Amapa, Curso Farm, Lab Absorcao Atom & Bioprospeccao, Macapa, AP, Brazil
关键词
Evening primrose; Nanoemulsion; Oenothera biennis; STABILITY; EMULSIONS; SEEDS; L;
D O I
10.1016/j.bjp.2015.07.014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Evening primrose (Oenothera biennis L., Onagraceae) seeds oil has great economic importance due to its wide industrial application, mainly for medicines and nutraceutics. However, to our knowledge, it remains almost unexplored regarding development of innovative formulations, such as nanoemulsions. On the present study, required HydroprophileLipophile Balance of evening primrose seeds oil was determined (HLB 12) and a stable nanoemulsion (Day 1: mean droplet size: 214.3 +/- 0.69 nm, polydispersity index: 0.253 +/- 0.012. Day 7: mean droplet size: 202.8 +/- 0.23 nm, polydispersity index: 0.231 +/- 0.008) was achieved. Moreover, pseudo-ternary diagram allowed delimitation of nanoemulsion region, contributing to nanobiotechnology of natural products. (C) 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:422 / 425
页数:4
相关论文
共 50 条
  • [1] Development and characterization of evening primrose (Oenothera biennis) oil nanoemulsions
    Railane F. Rodrigues
    Isabele C. Costa
    Fernanda B. Almeida
    Rodrigo A. S. Cruz
    Adriana M. Ferreira
    Jessica C. E. Vilhena
    Alexandro C. Florentino
    José C. T. Carvalho
    Caio P. Fernandes
    Revista Brasileira de Farmacognosia, 2015, 25 : 422 - 425
  • [2] TRIACYLGLYCEROLS OF EVENING PRIMROSE (OENOTHERA-BIENNIS) SEED OIL
    RATNAYAKE, WMN
    MATTHEWS, DG
    ACKMAN, RG
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1989, 66 (07) : 966 - 969
  • [3] EVENING PRIMROSE (OENOTHERA-BIENNIS) OIL - A PAST AND PRESENT INTEREST IN A NOVEL OIL
    KIES, C
    CEREAL FOODS WORLD, 1988, 33 (08) : 668 - 668
  • [4] Phytochemical characterization of potential nutraceutical ingredients from Evening Primrose oil (Oenothera biennis L.)
    Montserrat-de la Paz, S.
    Fernandez-Arche, M. A.
    Angel-Martin, M.
    Garcia-Gimenez, M. D.
    PHYTOCHEMISTRY LETTERS, 2014, 8 : 158 - 162
  • [5] Isolation and characterization of polymorphic microsatellite loci in common evening primrose (Oenothera biennis)
    Larson, E. L.
    Bogdanowicz, S. M.
    Agrawal, A. A.
    Johnson, M. T. J.
    Harrison, R. G.
    MOLECULAR ECOLOGY RESOURCES, 2008, 8 (02) : 434 - 436
  • [6] Evening Primrose (Oenothera biennis) 'A miracle gift of nature' for females
    Aslam, Mahwish
    Rizwan, Bahisht
    Bashir, Shahid
    Amjad, Maria
    Bano, Sadia
    Abbas, Asra
    Sohail, Zuha
    Raza, Fatima
    Sahi, Azka Afzal
    BIOSCIENCE RESEARCH, 2021, 18 (04): : 3280 - 3292
  • [7] Common evening-primrose (Oenothera biennis L.)
    Steckel, Lawrence E.
    Sosnoskie, Lynn M.
    Steckel, Sandra J.
    WEED TECHNOLOGY, 2019, 33 (05) : 757 - 760
  • [8] DETERMINATION OF THE FATTY-ACIDS AND OIL CONTENT OF EVENING PRIMROSE (OENOTHERA-BIENNIS L)
    COURT, WA
    HENDEL, JG
    POCS, R
    FOOD RESEARCH INTERNATIONAL, 1993, 26 (03) : 181 - 186
  • [9] The effect of Oenothera biennis (Evening primrose) oil on inflammatory diseases: a systematic review of clinical trials
    Melika Sharifi
    Nasim Nourani
    Sarvin Sanaie
    Sanaz Hamedeyazdan
    BMC Complementary Medicine and Therapies, 24
  • [10] The effect of Oenothera biennis (Evening primrose) oil on inflammatory diseases: a systematic review of clinical trials
    Sharifi, Melika
    Nourani, Nasim
    Sanaie, Sarvin
    Hamedeyazdan, Sanaz
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)